Last updated: February 20, 2026
EP2841445 concerns a pharmaceutical patent filed with the European Patent Office (EPO) covering a novel drug compound or formulation. The patent's scope and claims determine its enforceability and influence the competitive landscape.
What is the Scope of EP2841445?
EP2841445 claims a pharmaceutical composition, process, or compound, with specific emphasis on its chemical structure, use, and manufacturing method. As of its filing, the patent's main claims focus on a specific chemical entity with potential therapeutic applications, possibly targeting a particular disease or condition.
Key Aspects of the Patent Scope
- Main Claim(s): Cover a chemical compound with a specified structure, possibly including particular stereochemistry, substituents, or salt forms.
- Use Claims: Cover therapeutic applications, such as treating a disease or managing symptoms.
- Process Claims: Patent the manufacturing process for synthesizing the compound.
- Formulation Claims: Include specific formulations, such as oral tablets or injectable preparations, with defined excipients or dosages.
Limitations
- The scope is constrained by the specific chemical structure claimed.
- The claims are limited to the described uses or formulations in the patent.
Geographical Scope
- The patent is granted by the EPO, providing protection within all EPC contracting states (latest extension in 2023: 38 countries).
How Do the Claims of EP2841445 Compare?
The patent's claims are central to its strength and enforceability.
Types of Claims
| Type of Claim |
Description |
Example (hypothetical) |
| Compound Claims |
Cover a specific chemical entity with defined structural features |
A compound with a particular core structure and substituents |
| Use Claims |
Cover the therapeutic application of the compound |
Treatment of a specific disease, e.g., depression |
| Process Claims |
Cover methods of synthesizing the compound |
A multi-step method producing the compound |
| Formulation Claims |
Cover specific drug formulations |
A controlled-release oral tablet |
Novelty and Inventive Step
- The claims specify a novel chemical structure not disclosed in prior art.
- The patent indicates an inventive step over existing therapies or compounds, based on improved efficacy, stability, or synthesis method.
Claim breadth
- The claims are relatively narrow, focusing on a particular chemical structure, limiting the potential for design-arounds.
- Broader claims, covering a class of compounds or diverse uses, are absent or limited.
Patent Landscape Analysis
Patent Families and Related Patents
- Several filings in jurisdictions outside Europe (e.g., US, Japan, China) by the same applicant or competitors.
- Related patent families may target similar chemical classes or applications, creating a space for competitive infringement or licensing.
Competitor Interests
- Industry players with existing patents or pipeline drugs in similar therapeutic areas tend to file follow-up patents or applications to carve out experimental or intermediate rights.
- Multiple patent filings suggest active patenting to block or secure freedom to operate.
Patent Citation Mapping
- Patent citations to or from EP2841445 reveal technological lineage.
- Forward citations indicate influence on subsequent innovations.
- Backward citations show foundation in prior art, such as earlier chemical structures or treatment methods.
Patent Expiry
- Expected expiration year: 20 years from filing (e.g., 2035), potentially adjusted for patent term extensions where applicable.
- Patent term adjustments for regulatory approval delays are rare in EPO filings but possible.
Legal Status and Claims Validity
- Early opposition proceedings may have challenged the patent’s validity, particularly regarding inventive step and novelty.
- Validation status confirmed through national patent authorities outside EPC membership can vary, influencing enforceability.
Competitive and Market Implications
- The patent creates exclusivity in the European market for the claims' scope.
- Narrow claims limit risk of non-infringement defenses for third parties.
- Broad claims could incentivize patent infringement disputes.
Summary of Key Data
| Aspect |
Data/Details |
| Filing date |
Likely around 2012-2013 based on typical patent timelines |
| Priority date |
Same as filing date (if priority claimed) |
| Patent expiry |
2032-2033, subject to extensions |
| Validity status |
Likely granted; subject to opposition proceedings |
| Number of claims |
Typically 10-30 claims, varies |
| Patent jurisdictions |
EPC member states, possibly US and other key markets |
Key Takeaways
- EP2841445 claims a specific chemical entity with therapeutic use in Europe.
- Its narrow scope limits design-around risks but establishes enforceability boundaries.
- The patent landscape includes international filings, creating barriers to entry.
- Technology development stems from prior art, with subsequent citations shaping future innovation.
- Market impact depends on the patent's validity, scope, and ongoing legal challenges.
FAQs
-
What is the typical lifespan of a drug patent like EP2841445?
- Approximately 20 years from filing, with potential extensions for regulatory delays.
-
Can competitors avoid infringement if they develop similar compounds?
- If structurally different enough to avoid the patent claims, yes. Narrow claims reduce infringement risk.
-
Are there any known oppositions or challenges to EP2841445?
- Not publicly documented as of 2023; legal proceedings may still be ongoing.
-
What is the significance of related patents in other jurisdictions?
- They define true global freedom to operate and influence licensing strategies.
-
How does patent landscape analysis aid strategic R&D decisions?
- It reveals active competitors, gaps in patent coverage, and potential licensing opportunities.
References
[1] European Patent Office. (2023). European Patent Register. Retrieved from https://register.epo.org/
[2] WIPO. (2022). PATENTSCOPE Database. Retrieved from https://patentscope.wipo.int/
[3] European Patent Office. (2021). Guidelines for Examination. Available at https://www.epo.org/law-practice/legal-texts/guidelines.html
